211 related articles for article (PubMed ID: 10212525)
21. Patents and access to drugs in developing countries: an ethical analysis.
Sterckx S
Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
[TBL] [Abstract][Full Text] [Related]
22. An economic justification for open access to essential medicine patents in developing countries.
Flynn S; Hollis A; Palmedo M
J Law Med Ethics; 2009; 37(2):184-208. PubMed ID: 19493066
[TBL] [Abstract][Full Text] [Related]
23. The role of university technology transfer operations in assuring access to medicines and vaccines in developing countries.
Nelsen L
Yale J Health Policy Law Ethics; 2003; 3(2):301-8. PubMed ID: 14577146
[No Abstract] [Full Text] [Related]
24. Patents and access to essential drugs.
Loff B
Trans R Soc Trop Med Hyg; 2003; 97(1):6-9. PubMed ID: 12886793
[TBL] [Abstract][Full Text] [Related]
25. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
Cohen-Kohler JC; Forman L; Lipkus N
Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
[TBL] [Abstract][Full Text] [Related]
26. Patent Funded Access to Medicines.
Andreassen T
Dev World Bioeth; 2015 Dec; 15(3):152-61. PubMed ID: 24750573
[TBL] [Abstract][Full Text] [Related]
27. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
Viana JM
Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
[No Abstract] [Full Text] [Related]
28. [Access of developing countries to essential drugs: a process of equity].
Campion MD
Bull Acad Natl Med; 2001; 185(7):1255-66; discussion 1266-9. PubMed ID: 11975322
[TBL] [Abstract][Full Text] [Related]
29. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
Rosina MS; Shaver L
J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
[TBL] [Abstract][Full Text] [Related]
30. The morally uncomfortable global drug gap.
Cohen-Kohler JC
Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
[TBL] [Abstract][Full Text] [Related]
31. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
[TBL] [Abstract][Full Text] [Related]
32. Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
Bird RC
J Law Med Ethics; 2009; 37(2):209-21. PubMed ID: 19493067
[TBL] [Abstract][Full Text] [Related]
33. Human rights and fair access to medication.
Rubenstein LS
Emory Int Law Rev; 2003; 17():525-34. PubMed ID: 15732190
[No Abstract] [Full Text] [Related]
34. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
Sawyer E
AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
[TBL] [Abstract][Full Text] [Related]
35. Patents & public health: international trade obligations and domestic policy development.
Amani B
Health Law Can; 2002 Feb; 22(3):76-84. PubMed ID: 11915591
[No Abstract] [Full Text] [Related]
36. Implications of bilateral free trade agreements on access to medicines.
Correa CM
Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
[TBL] [Abstract][Full Text] [Related]
37. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
Ghosh S
Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
[No Abstract] [Full Text] [Related]
38. U.S. blocks trade agreement on generic drug access in poor countries.
James JS
AIDS Treat News; 2002 Dec; (386):4-6. PubMed ID: 12569874
[TBL] [Abstract][Full Text] [Related]
39. Is globalization good for your health?
Dollar D
Bull World Health Organ; 2001; 79(9):827-33. PubMed ID: 11584730
[TBL] [Abstract][Full Text] [Related]
40. UK Commission concludes international patent laws hinder access to medicines in developing countries.
Elliott R
Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):59. PubMed ID: 14740605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
